Jeffrey Leebaw News
-
Smith & Nephew Plc , which gained 16 percent on takeover speculation, is still worth almost 60 percent more, or $15.6 billion, in an acquisition.
-
Johnson & Johnson, the world’s largest maker of health-care products, is considering a fresh takeover bid for Smith & Nephew Plc, the Sunday Times reported, without saying how it got the information.
-
Johnson & Johnson and AstraZeneca Plc stopped studies of experimental painkillers over concerns that a class of drugs once expected to generate as much as $11 billion in annual sales may raise the risk of joint damage.
-
Johnson & Johnson is setting in motion a competition to replace Chief Executive Officer William Weldon by promoting the heads of its drug and device units to vice chairmen and assigning them to repair its consumer business following product recalls.
-
Amgen Inc. , the world’s largest biotechnology company, is considering a takeover offer for Actelion Ltd. to gain new medicines for rare diseases, and may approach the Swiss drugmaker as early as this week, said two people with knowledge of the matter.
-
Edwards Lifesciences Corp. may double annual revenue and become a buyout target with U.S. approval of a $30,000 cardiac valve that can be implanted without open heart surgery.
-
A federal judge threw out claims by Intel Corp. that accused the University of Wisconsin of accepting money to begin a research program and then demanding billions of dollars in royalties on the work.
-
Sanofi-Aventis SA ’s three-month effort to acquire Genzyme Corp. took a more contentious turn as the companies’ chief executive officers offered conflicting accounts of their face-to-face meeting last month.
-
Sanofi-Aventis SA Chief Executive Chris Viehbacher provided a possible price range of $69 to $80 a share to buy Genzyme Corp. at a Sept. 20 meeting with the U.S. company’s chief, Genzyme said.
-
U.S. lawmakers investigating whether Johnson & Johnson used a “phantom recall” to remove Motrin packages from the market without regulators’ knowledge asked the drugmaker if outside contractors were hired to buy other products in stores as well.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page